Portland, United States
Trace Biosciences, Inc.
undisclosed funding
Series A
Summary
Trace Biosciences, Inc. received a strategic investment from Axogen to advance the clinical development of its Nerve Trace nerve-specific imaging technology. The investment is part of Trace's Series A financing round, and proceeds will support Phase II and III clinical trials. Trace Biosciences, Inc. is a clinical-stage biotechnology company developing nerve-targeted imaging agents.